Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics | $5.88 | -$7.79 | -56.99% | 57.6K | $42M | $5.01$19.15 |
| LYRA | Lyra Therapeutics | $2.06 | -$1.71 | -45.31% | 21.2K | $3.7M | $1.63$37.50 |
| LXEO | Lexeo Therapeutics | $8.12 | -$2.42 | -22.96% | 3.7K | $593M | $1.45$10.99 |
| ATEC | Alphatec | $17.59 | -$5.06 | -22.34% | 2.9K | $2.6B | $8.81$23.29 |
| THH | TryHard | $23.10 | -$6.37 | -21.61% | 101K | $1.2B | $4.00$30.52 |
| DGNX | Diginex | $2.42 | -$0.66 | -21.43% | 98.3K | $489M | $0.45$39.85 |
| NUVB | Nuvation Bio | $6.46 | -$1.58 | -19.65% | 53.2K | $2.2B | $1.54$9.75 |
| CLNN | Clene | $5.18 | -$1.22 | -19.00% | 1.3K | $54M | $2.28$13.50 |
| SEV | Aptera Motors | $3.99 | -$0.90 | -18.41% | 250 | $110M | $3.55$40.85 |
| AZI | Autozi Internet Technology (Global) | $2.62 | -$0.57 | -17.87% | 30.9K | $268M | $1.33$69.00 |
Related Articles
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
Cory Renauer|Oct 29, 2024
It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.
Is Abercrombie & Fitch's Pullback a Buying Opportunity?
Leo Sun|Sep 1, 2024
The apparel retailer's turnaround story isn't over yet.
Advertisement
Mall Retailers Are Alive and Well
Motley Fool Staff|Jun 7, 2024
Abercrombie & Fitch and Dick's Sporting Goods show that familiar names near the food court are doing just fine.
Peloton's Woes and Abercrombie & Fitch's Latest Resurgence
Motley Fool Staff|Sep 3, 2023
Abercrombie is back in vogue, but be careful chasing this cyclical business.
2 Retail Stocks Leading Markets Higher Wednesday
Dan Caplinger|Aug 23, 2023
Forget what you've heard about consumer weakness, at least with these companies.
Missed Out On Intuitive Surgical's Boom? This Stock May Be a Better Buy Now
James Halley|Jun 6, 2023
Alphatec's strong revenue growth makes it worth watching.
Abercrombie & Fitch Stock: Buy, Sell, or Hold?
Leo Sun|May 26, 2023
The apparel retailer seems to have turned a corner.
2 Best Growth Stocks to Buy in April
George Budwell, PhD|Apr 3, 2023
Takeover interest is spurring these two biotech stocks higher.
Wall Street Upgraded This Stock's Price Target After a New Approval: Is It a Buy?
James Halley|Feb 27, 2023
The company's lead therapy was just approved for another indication.
